<DOC>
	<DOCNO>NCT01064349</DOCNO>
	<brief_summary>This retrospective cohort study aim improve understand current paradigm treatment brain metastasis erbB2+ breast cancer patient Asia Pacific region . We aim identify approximately 300 erbB2+ breast cancer patient brain metastasis diagnose 2006-2008 6 country . Medical record analyze determine treatment pattern brain metastasis , include anti-erbB2 therapy . Additional objective understand impact anti-erbB2 therapy survival brain metastasis investigate relationship anti-erbB2 therapy brain metastasis : 1 ) time interval diagnosis erb2+ breast cancer brain metastasis , 2 ) occurrence brain metastasis first site disease progression .</brief_summary>
	<brief_title>Breast Cancer With Over-expression erbB2-BRAINSTORM</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>1 . Female patient diagnose erbB2+ breast cancer . ErbB2 positivity determine respective institutional standard , base medical history . 2 . Brain metastasis diagnosis make January 2006 December 2008 . 1 . Women another primary cancer diagnose time breast cancer diagnosis brain metastasis.. 2 . Patient leptomeningeal metastasis without parenchymal brain involvement ( since pattern disease require different treatment approach . )</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>brain metastasis</keyword>
	<keyword>ErbB2 treatment</keyword>
	<keyword>ErbB2+ breast cancer</keyword>
</DOC>